Date: 2014-08-19
Type of information: Construction of a production plant
Compound:
Company: Baxter (USA - IL)
Therapeutic area: Renal diseases - Kidney diseases
Type agreement:
Action mechanism:
Disease:
Details: * On August 19, 2014, Baxter International announced that it plans to expand its state-of-the-art manufacturing facility in Opelika, Ala. , to help address the growing global demand for dialyzers, a critical component used in hemodialysis therapy (HD). Baxter will invest nearly $300 million in the Opelika site to add 230,000 square feet and several production lines. The company currently employs about 170 people at the facility, and anticipates it will begin the hiring process of the additional 200 workers in 2016 to support the expansion, which is when the first commercial production on the new lines is slated to begin.
Financial terms:
Latest news:
